ERNA

Ernexa Therapeutics Inc. ERNA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ERNA INAB APVO HCWB CING MTNB EPIX KALA ABP KPRX
6M -51.81 % -55.39 % -91.30 % -43.91 % -5.86 % 227.43 % -88.63 % -59.80 % -19.80 % -1.09 %
YTD -75.99 % -74.91 % -98.30 % -76.35 % -22.84 % 214.63 % -89.01 % -81.91 % -87.43 % -24.02 %
1Y -92.01 % -69.29 % -98.65 % -82.17 % -10.57 % -52.44 % -96.71 % -73.48 % -96.58 % -20.00 %
3Y -98.20 % -96.24 % -100.00 % -95.35 % -98.53 % -94.56 % -89.79 % -88.80 % -96.58 % -95.09 %
5Y -99.90 % -99.30 % -100.00 % -98.30 % -99.63 % -95.86 % -97.01 % -99.65 % -96.58 % -99.80 %
10Y -99.99 % -99.30 % -100.00 % -98.30 % -99.63 % -95.19 % -99.85 % -99.85 % -96.58 % -99.98 %
From the beginning -100.00 % -99.30 % -100.00 % -98.30 % -99.63 % -97.15 % -99.77 % -99.85 % -96.58 % -99.99 %

Dividend

ESSA Pharma Inc.